Component
Oxidative haemolysis of human beta-thalassemic erythrocytes
Experimental species, exposure and limitations are retained on each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Added indicaxanthin increased resistance of beta-thalassemic red cells to peroxide-induced haemolysis.
Experimental context and source evidence
- dose
- Indicaxanthin 1-10 micromolar; cumene hydroperoxide challenge
- duration
- Not specified in accessed abstract
- evidence_access
- Primary PubMed abstract.
- evidence_scope
- literature_reviewed; model-specific source-derived curation
- experimental_model
- Human beta-thalassemia donor erythrocytes
- limitations
- Ex vivo redox protection is not demonstrated oral treatment of anemia; preservation is not proof of increased glutathione synthesis.
- nutrient_topic
- Dedicated indicaxanthin chapter; original betalain family identity and shared claims preserved. · Indicaxanthin
- organism
- Human beta-thalassemia donor erythrocytes
- plain_language
- Added indicaxanthin increased resistance of beta-thalassemic red cells to peroxide-induced haemolysis.
- primary_references
- Cytoprotective effects of the antioxidant phytochemical indicaxanthin in beta-thalassemia red blood cells. (2006). https://pubmed.ncbi.nlm.nih.gov/16984002/ DOI: 10.1080/10715760600554228
- route
- Ex vivo addition
- tissue
- Red blood cells
Indicaxanthin: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 19–28
Original AI-assisted curation of thirteen additional primary studies, with twenty-six existing claims from eight studies linked unchanged. Study-specific citations and limitations retained. Not publisher full text. · supports · Human beta-thalassemia donor erythrocytes · source_derived_draft · unverified_draft
## indicaxanthin-rbc-haemolysis Added indicaxanthin increased resistance of beta-thalassemic red cells to peroxide-induced haemolysis. Model/species: Human beta-thalassemia donor erythrocytes Tissue: Red blood cells Exposure: Indicaxanthin 1-10 micromolar; cumene hydroperoxide challenge Route: Ex vivo addition Duration: Not specified in accessed abstract Limits: Ex vivo redox protection is not demonstrated oral treatment of anemia; preservation is not proof of increased glutathione synthesis. Primary reference: Cytoprotective effects of the antioxidant phytochemical indicaxanthin in beta-thalassemia red blood cells. (2006). https://pubmed.ncbi.nlm.nih.gov/16984002/ DOI: 10.1080/10715760600554228 Access: Primary PubMed abstract.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.